ES2522873T3 - Combinaciones farmacéuticas que contienen un antagonista de receptor de angiotensina II, hidroclorotiazida y un disgregante - Google Patents
Combinaciones farmacéuticas que contienen un antagonista de receptor de angiotensina II, hidroclorotiazida y un disgregante Download PDFInfo
- Publication number
- ES2522873T3 ES2522873T3 ES13150074.6T ES13150074T ES2522873T3 ES 2522873 T3 ES2522873 T3 ES 2522873T3 ES 13150074 T ES13150074 T ES 13150074T ES 2522873 T3 ES2522873 T3 ES 2522873T3
- Authority
- ES
- Spain
- Prior art keywords
- pharmaceutical composition
- crospovidone
- hydrochlorothiazide
- starch glycolate
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR201004754 | 2010-06-11 | ||
TR2010/04754A TR201004754A1 (tr) | 2010-06-11 | 2010-06-11 | Yeni Farmasötik Kombinasyonlar |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2522873T3 true ES2522873T3 (es) | 2014-11-18 |
Family
ID=43303905
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES13150074.6T Active ES2522873T3 (es) | 2010-06-11 | 2011-06-10 | Combinaciones farmacéuticas que contienen un antagonista de receptor de angiotensina II, hidroclorotiazida y un disgregante |
ES11169599T Active ES2424469T3 (es) | 2010-06-11 | 2011-06-10 | Nuevas combinaciones farmacéuticas |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES11169599T Active ES2424469T3 (es) | 2010-06-11 | 2011-06-10 | Nuevas combinaciones farmacéuticas |
Country Status (7)
Country | Link |
---|---|
US (1) | US20110305757A1 (da) |
EP (2) | EP2586424B1 (da) |
DK (1) | DK2394638T3 (da) |
ES (2) | ES2522873T3 (da) |
PL (2) | PL2394638T3 (da) |
PT (1) | PT2394638E (da) |
TR (1) | TR201004754A1 (da) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR201007508A1 (tr) * | 2010-09-14 | 2012-04-24 | Sanovel İlaç San. Ve Ti̇c. A.Ş. | Oral yolla dağılan bileşimler |
KR101414873B1 (ko) * | 2012-06-28 | 2014-07-03 | 보령제약 주식회사 | 피마살탄 및 히드로클로로티아지드가 함유된 약제학적 조성물 |
WO2014102628A1 (en) * | 2012-12-31 | 2014-07-03 | Ranbaxy Laboratories Limited | Stable pharmaceutical composition comprising azilsartan medoxomil |
EP3492466B1 (en) * | 2016-07-29 | 2022-06-01 | Wuhan LL Science And Technology Development Co., Ltd. | Oral solid preparation and use thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2125251C (en) * | 1993-06-07 | 2005-04-26 | Yoshiyuki Inada | A pharmaceutical composition for angiotensin ii-mediated diseases |
AU716519B2 (en) * | 1995-06-30 | 2000-02-24 | Laboratoires Merck Sharp & Dohme - Chibret Snc | Method of treating renal disease using an ace inhibitor and an A II antagonist |
JP5607550B2 (ja) * | 2008-03-11 | 2014-10-15 | ディポメド,インコーポレイティド | 非オピオイド鎮痛剤及びオピオイド鎮痛剤の組合せを含む胃保持性持続放出剤形 |
EP2252273B1 (en) * | 2008-03-19 | 2016-12-28 | ratiopharm GmbH | Solid pharmaceutical composition comprising a non-peptide angiotensin ii receptor antagonist and a diuretic |
TW201014850A (en) * | 2008-09-25 | 2010-04-16 | Takeda Pharmaceutical | Solid pharmaceutical composition |
-
2010
- 2010-06-11 TR TR2010/04754A patent/TR201004754A1/xx unknown
-
2011
- 2011-06-10 ES ES13150074.6T patent/ES2522873T3/es active Active
- 2011-06-10 EP EP13150074.6A patent/EP2586424B1/en not_active Not-in-force
- 2011-06-10 PL PL11169599T patent/PL2394638T3/pl unknown
- 2011-06-10 PL PL13150074T patent/PL2586424T3/pl unknown
- 2011-06-10 ES ES11169599T patent/ES2424469T3/es active Active
- 2011-06-10 EP EP11169599.5A patent/EP2394638B1/en not_active Not-in-force
- 2011-06-10 PT PT111695995T patent/PT2394638E/pt unknown
- 2011-06-10 DK DK11169599.5T patent/DK2394638T3/da active
- 2011-06-13 US US13/159,049 patent/US20110305757A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2586424A1 (en) | 2013-05-01 |
US20110305757A1 (en) | 2011-12-15 |
EP2586424B1 (en) | 2014-08-13 |
EP2394638B1 (en) | 2013-05-08 |
EP2394638A1 (en) | 2011-12-14 |
PT2394638E (pt) | 2013-08-22 |
PL2586424T3 (pl) | 2015-03-31 |
TR201004754A1 (tr) | 2012-01-23 |
ES2424469T3 (es) | 2013-10-02 |
DK2394638T3 (da) | 2013-07-15 |
PL2394638T3 (pl) | 2014-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4891774B2 (ja) | ナノ粒子のメロキシカム製剤 | |
ES2757882T5 (es) | Formulaciones de comprimidos de maleato de neratinib | |
ES2299441T3 (es) | Forma en estado solido de celecoxib con biodisponibilidad potenciada. | |
TWI399223B (zh) | 奧美沙坦酯及氨氯地平之固體劑型 | |
ES2290457T3 (es) | Tableta con alta carga de farmaco. | |
ES2435240T3 (es) | Composiciones de dosis fija farmacéuticas sólidas que comprenden irbesartán y amlodipina, su preparación y su aplicación terapéutica | |
PL200957B1 (pl) | Kompozycja farmaceutyczna celecoxib'u i zastosowanie kompozycji farmaceutycznej | |
EP2252273B1 (en) | Solid pharmaceutical composition comprising a non-peptide angiotensin ii receptor antagonist and a diuretic | |
CN106074445B (zh) | 包衣药物球状体及其制备消除或减少病症的药物的用途 | |
JP6231959B2 (ja) | カルシウム拮抗薬/アンジオテンシンii受容体拮抗薬含有医薬製剤 | |
ES2522873T3 (es) | Combinaciones farmacéuticas que contienen un antagonista de receptor de angiotensina II, hidroclorotiazida y un disgregante | |
KR20140092316A (ko) | 의약조성물 | |
ES2366394T3 (es) | Composiciones de eprosartán. | |
US20170014340A1 (en) | Orally Disintegrating Tablet of Nabilone Comprising Mannitol-Based Granules | |
WO2014104929A1 (ru) | Фармацевтическая композиция для лечения вич-инфекции | |
JP2019529486A (ja) | カンデサルタンおよびアムロジピンを含む単一層からなる複合製剤 | |
JP5635491B2 (ja) | 固形医薬組成物 | |
ES2663721T3 (es) | Formulaciones de olmesartán | |
ES2547138T3 (es) | Composiciones que se disgregan por vía oral | |
KR20230008783A (ko) | 아비라테론 아세테이트 및 니라파립의 약제학적 제형 | |
Sharma et al. | Attempts and outcomes of liquisolid technology: An updated chronological compilation of innovative ideas and adjuvants in the field | |
JP2009542806A (ja) | 感湿性薬物及び第2薬物の組合せを含んで成る安定製剤及びその製造方法 |